Restricted accessResearch articleFirst published online 2025-7
Individual electric field in cortical white matter is correlated with cognitive improvement in patients with mild cognitive impairment due to Alzheimer's disease after repetitive transcranial magnetic stimulation treatment
Repetitive transcranial magnetic stimulation (rTMS) may be effective for Alzheimer's disease (AD) and mild cognitive impairment (MCI); however, the therapeutic efficacy varies significantly, highlighting the need for reliable biomarkers to predict treatment response. While rTMS may activates cortical white matter, the relationship between induced electric field (E-field) in this region and clinical outcomes remains unclear.
Objective
This study characterized the E-field in cortical gray matter (EFgm), cortical white matter (EFwm), and region-of-interest (EFROI) in the left dorsolateral prefrontal cortex (DLPFC), and explored their correlations with treatment efficacy in patients with MCI due to AD.
Methods
Thirty patients with MCI due to AD received 2-week rTMS treatment, with efficacy measured by Auditory Verbal Learning Test (AVLT) and a comprehensive neuropsychological battery. Responders were defined as those with >25% improvement in AVLT-immediate memory. Correlations between regional brain volumes and E-field magnitudes, and the correlations between E-field magnitudes and cognitive improvement, were analyzed. Predictive performance of E-fields for responder classification was evaluated.
Results
Pronounced inter-individual variability in magnitudes of EFgm, EFwm and EFROI was observed, partially explained by differences in regional brain volumes of DLPFC targeted area. Treatment responders exhibited significantly higher EFwm magnitude. EFwm positively correlated with AVLT-immediate memory improvement (R2 = 0.37) and predicted responder groups, achieving an area under the curve (AUC) of 0.76.
Conclusions
E-field within cortical white matter in the DLPFC correlates with rTMS efficacy and predicts therapeutic response in MCI due to AD. Personalized stimulation protocols incorporating EFwm modeling may optimize treatment parameters.
Trial registration
This study is registered in the Chinese Clinical Trial Registry, number ChiCTR2200062564, date of registration: 2022-08-11.
ScheltensPDe StrooperBKivipeltoM, et al.Alzheimer's disease. Lancet2021; 397: 1577–1590.
2.
GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol2019; 18: 459–480.
3.
JuckerMWalkerLC. Alzheimer's disease: from immunotherapy to immunoprevention. Cell2023; 186: 4260–4270.
AlbertMSDeKoskySTDicksonD, et al.The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement2011; 7: 270–279.
6.
van DyckCHSwansonCJAisenP, et al.Lecanemab in early Alzheimer's disease. N Engl J Med2023; 388: 9–21.
7.
SimsJRZimmerJAEvansCD, et al.Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA2023; 330: 512–527.
8.
AntalALuberBBremAK, et al.Non-invasive brain stimulation and neuroenhancement. Clin Neurophysiol Pract2022; 7: 146–165.
9.
SharbafshaaerMGigiILavorgnaL, et al.Repetitive transcranial magnetic stimulation (rTMS) in mild cognitive impairment: effects on cognitive functions-A systematic review. J Clin Med2023; 12: 6190.
10.
HallettM. Transcranial magnetic stimulation: a primer. Neuron2007; 55: 187–199.
11.
SiebnerHRFunkeKAberraAS, et al.Transcranial magnetic stimulation of the brain: what is stimulated? - A consensus and critical position paper. Clin Neurophysiol2022; 140: 59–97.
12.
AhmedMADarwishESKhedrEM, et al.Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia. J Neurol2012; 259: 83–92.
13.
ChouYHTon ThatVSundmanM. A systematic review and meta-analysis of rTMS effects on cognitive enhancement in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging2020; 86: 1–10.
14.
WuXJiGJGengZ, et al.Accelerated intermittent theta-burst stimulation broadly ameliorates symptoms and cognition in Alzheimer's disease: a randomized controlled trial. Brain Stimul2022; 15: 35–45.
15.
SabbaghMSadowskyCTousiB, et al.Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease. Alzheimers Dement2020; 16: 641–650.
16.
KochGCasulaEPBonnìS, et al.Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial. Brain2022; 145: 3776–3786.
17.
LeeJChoiBHOhE, et al.Treatment of Alzheimer's disease with repetitive transcranial magnetic stimulation combined with cognitive training: a prospective, randomized, double-blind, placebo-controlled study. J Clin Neurol2016; 12: 57–64.
18.
BremAKDi IorioRFriedPJ, et al.Corticomotor plasticity predicts clinical efficacy of combined neuromodulation and cognitive training in Alzheimer's disease. Front Aging Neurosci2020; 12: 200.
19.
LiXQiGYuC, et al.Cortical plasticity is correlated with cognitive improvement in Alzheimer's disease patients after rTMS treatment. Brain Stimul2021; 14: 503–510.
20.
KochGBonnìSPellicciariMC, et al.Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease. Neuroimage2018; 169: 302–311.
21.
Drumond MarraHLMyczkowskiMLMaia MemóriaC, et al.Transcranial magnetic stimulation to address mild cognitive impairment in the elderly: a randomized controlled study. Behav Neurol2015; 2015: 287843.
22.
SenczyszynASzcześniakDWieczorekT, et al.Improvement of working memory in older adults with mild cognitive impairment after repetitive transcranial magnetic stimulation - A randomized controlled pilot study. Front Psychiatry2023; 14: 1196478.
23.
CuiHRenRLinG, et al.Repetitive transcranial magnetic stimulation induced hypoconnectivity within the default mode network yields cognitive improvements in amnestic mild cognitive impairment: a randomized controlled study. J Alzheimers Dis2019; 69: 1137–1151.
24.
Roque RoqueGYReyes-LópezJVGarcellRJ, et al.Effect of transcranial magnetic stimulation as an enhancer of cognitive stimulation sessions on mild cognitive impairment: preliminary results. Psychiatry Res2021; 304: 114151.
25.
HuangYZEdwardsMJRounisE, et al.Theta burst stimulation of the human motor cortex. Neuron2005; 45: 201–206.
26.
NeuteboomDZantvoordJBGoya-MaldonadoR, et al.Accelerated intermittent theta burst stimulation in major depressive disorder: a systematic review. Psychiatry Res2023; 327: 115429.
27.
WuXYanYHuP, et al.Effects of a periodic intermittent theta burst stimulation in Alzheimer's disease. Gen Psychiatr2024; 37: e101106.
28.
LongJMHoltzmanDM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell2019; 179: 312–339.
29.
ChenXDongGYWangLX. High-frequency transcranial magnetic stimulation protects APP/PS1 mice against Alzheimer's disease progress by reducing APOE and enhancing autophagy. Brain Behav2020; 10: e01740.
30.
HuangZTanTduY, et al.Low-frequency repetitive transcranial magnetic stimulation ameliorates cognitive function and synaptic plasticity in APP23/PS45 mouse model of Alzheimer's disease. Front Aging Neurosci2017; 9: 292.
31.
PagaliSRKumarRLeMahieuAM, et al.Efficacy and safety of transcranial magnetic stimulation on cognition in mild cognitive impairment, Alzheimer's disease, Alzheimer's disease-related dementias, and other cognitive disorders: a systematic review and meta-analysis. Int Psychogeriatr2024; 36: 880–928.
32.
YanYTianMWangT, et al.Transcranial magnetic stimulation effects on cognitive enhancement in mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. Front Neurol2023; 14: 1209205.
33.
PhilipNSSorensenDOMcCalleyDM, et al.Non-invasive brain stimulation for alcohol use disorders: state of the art and future directions. Neurotherapeutics2020; 17: 116–126.
RajkowskaGGoldman-RakicPS. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: i. Remapping of areas 9 and 46 using quantitative criteria. Cereb Cortex1995; 5: 307–322.
36.
BakkourAMorrisJCWolkDA, et al.The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition. Neuroimage2013; 76: 332–344.
37.
GeeterNDDupréLCrevecoeurG. Modeling transcranial magnetic stimulation from the induced electric fields to the membrane potentials along tractography-based white matter fiber tracts. J Neural Eng2016; 13: 026028.
38.
Gomez-TamesJLaaksoIMurakamiT, et al.TMS Activation site estimation using multiscale realistic head models. J Neural Eng2020; 17: 036004.
39.
GoodwinBDButsonCR. Subject-specific multiscale modeling to investigate effects of transcranial magnetic stimulation. Neuromodulation2015; 18: 694–704.
40.
SalvadorRSilvaSBasserPJ, et al.Determining which mechanisms lead to activation in the motor cortex: a modeling study of transcranial magnetic stimulation using realistic stimulus waveforms and sulcal geometry. Clin Neurophysiol2011; 122: 748–758.
41.
OpitzAWindhoffMHeidemannRM, et al.How the brain tissue shapes the electric field induced by transcranial magnetic stimulation. Neuroimage2011; 58: 849–859.
42.
WinbladBPalmerKKivipeltoM, et al.Mild cognitive impairment—beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. J Intern Med2004; 256: 240–246.
43.
American Psychiatric Association. DSM-IV: diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
44.
ScheltensPLeysDBarkhofF, et al.Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry1992; 55: 967–972.
45.
DannhauerMGomezLJRobinsPL, et al.Electric field modeling in personalizing transcranial magnetic stimulation interventions. Biol Psychiatry2024; 95: 494–501.
46.
WagnerTEdenUFregniF, et al.Transcranial magnetic stimulation and brain atrophy: a computer-based human brain model study. Exp Brain Res2008; 186: 539–550.
47.
BadranBWCaulfieldKALopezJW, et al.Personalized TMS helmets for quick and reliable TMS administration outside of a laboratory setting. Brain Stimul2020; 13: 551–553.
48.
KloosterDCWFergusonMABoonPAJM, et al.Personalizing repetitive transcranial magnetic stimulation parameters for depression treatment using multimodal neuroimaging. Biol Psychiatry Cogn Neurosci Neuroimaging2022; 7: 536–545.
49.
KähkönenSWileniusJKomssiS, et al.Distinct differences in cortical reactivity of motor and prefrontal cortices to magnetic stimulation. Clin Neurophysiol2004; 115: 583–588.
PaulkACZelmannRCrockerB, et al.Local and distant cortical responses to single pulse intracranial stimulation in the human brain are differentially modulated by specific stimulation parameters. Brain Stimul2022; 15: 491–508.
52.
CrockerBOstrowskiLWilliamsZM, et al.Local and distant responses to single pulse electrical stimulation reflect different forms of connectivity. Neuroimage2021; 237: 118094.
53.
GradinaruVMogriMThompsonKR, et al.Optical deconstruction of parkinsonian neural circuitry. Science2009; 324: 354–359.
54.
NummenmaaAMcNabJASavadjievP, et al.Targeting of white matter tracts with transcranial magnetic stimulation. Brain Stimul2014; 7: 80–84.
55.
NowakLGBullierJ. Axons, but not cell bodies, are activated by electrical stimulation in cortical gray matter. II. Evidence from selective inactivation of cell bodies and axon initial segments. Exp Brain Res1998; 118: 489–500.
56.
Jack JrCRBennettDABlennowK, et al.A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology2016; 87: 539–547.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
